Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment. Issue 4 (21st March 2021)

Record Type:
Journal Article
Title:
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment. Issue 4 (21st March 2021)
Main Title:
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment
Authors:
Gounot, Romain
Le Bras, Fabien
Dupuis, Jehan
Oghina, Silvia
Bodez, Diane
Roulin, Louise
Maarek, Alizee
Ladaique, Amandine
Beldi-Ferchiou, Asma
Poullot, Elsa
Molinier-Frenkel, Valerie
Haioun, Corinne
Damy, Thibaud
Belhadj, Karim
Lemonnier, François
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 62:Issue 4(2021)
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 4(2021)
Issue Display:
Volume 62, Issue 4 (2021)
Year:
2021
Volume:
62
Issue:
4
Issue Sort Value:
2021-0062-0004-0000
Page Start:
979
Page End:
983
Publication Date:
2021-03-21
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2020.1850717 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
16542.xml